Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vasomedical Inc (OP: VASO )

0.2400 UNCHANGED
Streaming Delayed Price Updated: 3:53 PM EDT, Jun 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 37,225
Open 0.2320
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2400
Today's Range 0.2300 - 0.2400
52wk Range 0.1910 - 0.3720
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Speculative Penny Stocks to Watch for Massive Upside
If you're looking for high-risk, high potential return opportunities, these are the top seven speculative penny stocks to buy. 
Via InvestorPlace
7 Undiscovered Penny Stocks Poised for Meteoric Rises
Each of these seven undiscovered penny stocks has the potential to experience a high level of price appreciation in the coming years. 
Via InvestorPlace

Performance

YTD
-20.00%
-20.00%
1 Month
+3.90%
+3.90%
3 Month
-22.08%
-22.08%
6 Month
-16.08%
-16.08%
1 Year
+5.31%
+5.31%

More News

Read More
Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger
Via ACCESSWIRE
Vaso Corporation Announces Financial Results for Third Quarter 2023
Via ACCESSWIRE
Q4 Stock Predictions: 7 Penny Stocks Ready to Roar Into 2024
Via InvestorPlace
Vaso Corporation Announces Financial Results for Second Quarter 2023
Via ACCESSWIRE
Vaso Corporation Announces Financial Results for First Quarter 2023
Via ACCESSWIRE
CORRECTION FROM SOURCE: Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2022
Via ACCESSWIRE
Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2022
Via ACCESSWIRE
OTC Markets Group Welcomes Vaso Corporation to OTCQX
From OTC Markets
Via GlobeNewswire
Vaso Corporation Announces Upgrade to OTCQX Best Market from OTCQB Venture Market
Via ACCESSWIRE
7 Best Penny Stocks Under $1 to Buy in May 2023
Via InvestorPlace
7 of the Best Penny Stocks Under $3 to Buy Right Now
Via InvestorPlace
Vaso Corporation Announces Financial Results for Third Quarter 2022
Via ACCESSWIRE
Vaso Corporation Announces Financial Results for Second Quarter 2022
Via ACCESSWIRE
Vaso Corporation Announces Up-listing to OTCQB Market
Via ACCESSWIRE
The 7 Best Penny Stocks for 10 Cents or Less
Via InvestorPlace
Vaso Corporation Announces Financial Results for First Quarter 2022
From Vaso Corporation
Via AccessWire
Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2021
From Vaso Corporation
Via AccessWire
Vaso Corporation Announces Financial Results for Third Quarter 2021
From Vaso Corporation
Via AccessWire
Topics Regulatory Compliance Supply Chain
Exposures COVID-19 Legal Regulatory
Vaso Corporation Announces Fourth Extension of Exclusive Sales Representation Agreement with GE Healthcare
From Vaso Corporation
Via AccessWire
Topics Regulatory Compliance Supply Chain
Exposures COVID-19 Legal Regulatory
Vaso Corporation Announces Financial Results for Second Quarter 2021
From Vaso Corporation
Via AccessWire
Topics Regulatory Compliance Supply Chain
Exposures COVID-19 Legal Regulatory
Vaso Corporation Receives Notice of PPP Loan Forgiveness
From Vaso Corporation
Via AccessWire
Topics Regulatory Compliance Supply Chain
Exposures COVID-19 Legal Regulatory
Vaso Corporation Announces Financial Results for First Quarter 2021
From Vaso Corporation
Via AccessWire
Topics Regulatory Compliance Supply Chain
Exposures COVID-19 Legal Regulatory
Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2020
From Vaso Corporation
Via AccessWire
Topics Regulatory Compliance Supply Chain
Exposures COVID-19 Legal Regulatory
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.